Atualmente, a quantidade de pacientes que são diagnosticados com alguma forma de depressão, entre elas, o transtorno depressivo maior, aumenta consideravelmente, quer seja em razão de diagnósticos mais precisos ou pela própria epidemiologia da doença. Acresça-se o fato de que muitos pacientes, apesar da quantidade de tipos de antidepressivos atualmente disponíveis para a terapêutica, são refratários ao tratamento prescrito, em razão dos efeitos adversos apresentados ou ainda em razão de simplesmente não se observar melhora com a prescrição. Em razão disso, novos tratamentos farmacológicos são disponibilizados. Para auxiliar na máxima eficácia em sua utilização, esse trabalho propôs o desenvolvimento de metodologia analítica para a determinação simultânea de antidepressivos tricíclicos e não tricíclicos, a saber: moclobemida, venlafaxina, citalopram, agomelatina, duloxetina, amitriptilina e sertralina em plasma humano por cromatografia líquida de alta eficiência (HPLC), para posteriormente ser aplicada na monitorização de pacientes depressivos. O método consistiu na extração líquido-líquido com recuperação entre 73% a 86%, exceto para a moclobemida (55%). A separação foi obtida usando uma coluna em fase reversa LiChrospher® 60 RP-select B em LichroCART 250mm x 4mm, 5 ?m de diâmetro interno, Merck sob condições isocráticas com detecção em UV em 230 nm, com fase móvel composta por 35% de uma mistura de acetonitrila/metanol 55/5 v/v e 65% de tampão acetato 0,25M pH 4,4. As curvas padrão foram lineares em uma faixa de trabalho de 2,5-1000 ng/mL para moclobemida, 5-2000 ng/mL para venlafaxina, citalopram, agomelatina, duloxetina e amitriptilina, 10-2000 ng/mL para sertralina. A precisão intra e interensaios foi efetuada em 3 concentrações (50, 200 e 500 ng/mL). Os coeficientes de variação para a precisão intraensaio foram menores que 8,8% para todos os compostos e os coeficientes de variação para a precisão interensaios foram menores que 8,6%. Os limites de quantificação foram de 2,5 ng/mL para a moclobemida, 5 ng/mL para venlafaxina, citalopram, duloxetina, agomelatina, amitriptilina e 10 ng/mL para sertralina com a etidocaína como padrão interno. Não se observou qualquer interferência das drogas normalmente associadas com antidepressivos. O método desenvolvido foi aplicado na monitorização de 79 pacientes em tratamento prolongado com amitriptilina, sertralina e venlafaxina. Paralelamente, foram avaliadas as concentrações plasmáticas de pacientes voluntários sadios submetidos a tratamento em dose única com agomelatina. A monitorização terapêutica se faz necessária para monitorar adesão ao tratamento já que a depressão está entre as principais causas mundiais de morbidade por incapacitação social e estimativa de prevalência crescente até 2030; caracterizando-se como um dos maiores e mais onerosos problemas de saúde pública. / Currently, the number of patients who are diagnosed with some form of depression, among them, major depressive disorder, increases considerably, either because of more accurate diagnosis or by the epidemiology of the disease. One should add the fact that many patients, despite the amount of types of antidepressants currently available for therapy are refractory to the treatment prescribed, because of the adverse effects appear, or their toxic effects, or by simply not observed improvement then the prescription. Therefore, new pharmacological treatments are available. To assist in maximum effectiveness in its use, this paper presents a methodology on HPLC for simultaneous determination of seven antidepressants, tricyclic and non-tricyclic, moclobemide, venlafaxine, citalopram, agomelatine, duloxetine, amitriptyline and sertraline in human plasma, later to be applied in monitoring depressed patients. The simple and accurate method of sample preparation consists of the liquid-liquid extraction with recovery between 73% to 86% (except for moclobemide, 55%). Separation was achieved using a reverse phase column Lichrospher® 60 RP-select B LiChroCART 4mm x 250mm, 5?m internal diameter, Merck, under isocratic conditions, with UV detection at 230nm, with a mobile phase consisting of a mixture of 35% acetonitrile:methanol 55/5 (v/v) and 65% 0.25M acetate buffer, pH 4.4. The standard curves were linear in the working range of 2,5-1000 ng/mL for moclobemide, 5-2000 ng/mL to venlafaxine, citalopram, agomelatine, duloxetine and amitriptyline and 10-2000ng/mL to sertraline. The intra and interassay precisions were performed at three concentrations (50, 200 and 500 ng/mL). The coefficients of variation for intra-assay precision were less than 8.6% for all compounds and the coefficients of variation for interassay precision were lower than 8.5%. The limits of quantification were 2.5 ng/mL for moclobemide, 5 ng/mL for venlafaxine, citalopram, duloxetine, agomelatine, amitriptyline and 10 ng/mL for sertraline. No interference of drugs normally associated with antidepressants was observed. The developed method was applied to the monitoring of 79 patients receiving prolonged treatment with amitriptyline, sertraline and venlafaxine. And, the plasma concentrations of healthy volunteer patients undergoing single dose agomelatine were evaluated. Therapeutic drug monitoring, is to ensure maximum clinical efficacy coupled with minimal adverse effects in patients undergoing long-term therapy is needed and to monitor adherence to treatment since depression is among the major causes of morbidity and social disability increasing prevalence estimate of 2030; characterized as one of the largest and most costly public health problems

Atualmente, a quantidade de pacientes que são diagnosticados com alguma forma de depressão, entre elas, o transtorno depressivo maior, aumenta consideravelmente, quer seja em razão de diagnósticos mais precisos ou pela própria epidemiologia da doença. Acresça-se o fato de que muitos pacientes, apesar da quantidade de tipos de antidepressivos atualmente disponíveis para a terapêutica, são refratários ao tratamento prescrito, em razão dos efeitos adversos apresentados, ou de seus efeitos tóxicos, ou ainda por simplesmente não se observar melhora com a prescrição seguida. Portanto, novos tratamentos farmacológicos são disponibilizados, e entre eles, a duloxetina, um duplo inibidor de recaptação de serotonina e norepinefrina. Para auxiliar na máxima eficácia em sua utilização, esse trabalho apresenta metodologia em HPLC para determinação simultânea de sete antidepressivos, tricíclicos e não tricíclicos, moclobemida, venlafaxina, citalopram, agomelatina, duloxetina, amitriptilina e sertralina, em plasma humano, para posteriormente ser aplicada na monitorização de pacientes depressivos. O simples e preciso método de preparo da amostra consiste na extração líquido-líquido, com recuperação entre 73% a 86% (exceto para moclobemida, de 55%), e para a duloxetina, de aproximadamente 73%. A separação foi obtida usando uma coluna em fase reversa Lichrospher® 60 RP-select B em LichroCART 250mm x 4mm, 5?m de diâmetro interno, Merck, sob condições isocráticas, com detecção em UV em 230nm, com fase móvel composta por 35% de uma mistura de acetonitrila:metanol 55/5 (v/v) e 65% de tampão acetato 0,25M, pH 4,4. As curvas padrões foram lineares em uma faixa de trabalho de 2,5-1000ng/mL para moclobemida, 5-2000ng/mL para venlafaxina, citalopram, agomelatina, duloxetina e amitriptilina, e 10-2000ng/mL para sertralina. As precisões intra e interensaios foram efetuadas em três concentrações (50, 200 e 500ng/mL). Os coeficientes de variação para a precisão intraensaio foram menores que 8,6% para todos os compostos e os coeficientes de variação para a precisão interensaio foram menores que 8,5%. Os limites de quantificação foram de 2,5ng/mL para a moclobemida, 5ng/mL para venlafaxina, citalopram, duloxetina, agomelatina, amitriptilina e 10ng/mL para sertralina. Não se observou qualquer interferência das drogas normalmente associadas aos antidepressivos. / Currently, the number of patients who are diagnosed with some form of depression, among them, major depressive disorder, increases considerably, either because of more accurate diagnosis or by the epidemiology of the disease. One should add the fact that many patients, despite the amount of types of antidepressants currently available for therapy are refractory to the treatment prescribed, because of the adverse effects appear, or their toxic effects, or by simply not observed improvement then the prescription. Therefore, new pharmacological treatments are available, and among them, duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine. To assist in maximum effectiveness in its use, this paper presents a methodology on HPLC for simultaneous determination of seven antidepressants, tricyclic and non-tricyclic, moclobemide, venlafaxine, citalopram, agomelatine, duloxetine, amitriptyline and sertraline in human plasma, later to be applied in monitoring depressed patients. The simple and accurate method of sample preparation consists of the liquid-liquid extraction with recovery between 73% to 86% (except for moclobemide, 55%), and duloxetine, of approximately 73%. Separation was achieved using a reverse phase column Lichrospher® 60 RP-select B LiChroCART 4mm x 250mm, 5?m internal diameter, Merck, under isocratic conditions, with UV detection at 230nm, with a mobile phase consisting of a mixture of 35% acetonitrile:methanol 55/5 (v/v) and 65% 0.25M acetate buffer, pH 4.4. The standard curves were linear in the working range of 2,5-1000ng/mL for moclobemide, 5-2000ng/mL to venlafaxine, citalopram, agomelatine, duloxetine and amitriptyline and 10-2000ng/mL to sertraline. The intra and interassay precisions were performed at three concentrations (50, 200 and 500ng/mL). The coefficients of variation for intra-assay precision were less than 8.6% for all compounds and the coefficients of variation for interassay precision were lower than 8.5%. The limits of quantification were 2.5ng/mL for moclobemide, 5ng/mL for venlafaxine, citalopram, duloxetine, agomelatine, amitriptyline and 10ng/mL for sertraline. No interference of drugs normally associated with antidepressants was observed.

Submitted by Renata Lopes (renatasil82@gmail.com) on 2017-05-10T11:56:06Z No. of bitstreams: 1 adrianaferreirafaria.pdf: 20849316 bytes, checksum: 511836cab839ebb39105bd682c987241 (MD5) / Approved for entry into archive by Adriana Oliveira (adriana.oliveira@ufjf.edu.br) on 2017-05-17T15:04:21Z (GMT) No. of bitstreams: 1 adrianaferreirafaria.pdf: 20849316 bytes, checksum: 511836cab839ebb39105bd682c987241 (MD5) / Made available in DSpace on 2017-05-17T15:04:21Z (GMT). No. of bitstreams: 1 adrianaferreirafaria.pdf: 20849316 bytes, checksum: 511836cab839ebb39105bd682c987241 (MD5) Previous issue date: 2010-08-13 / CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / O objetivo principal da tese em questão foi o desenvolvimento, otimização e validação de metodologias analíticas para análise de formulações farmacêuticas utilizadas no tratamento da tuberculose, as quais contêm como princípio ativo etambutol (ETB), isoniazida (ISO), rifampicina (RIF) e pirazinamida (PIR), isolados ou em associação. Inicialmente, duas metodologias analíticas para análise de ETB em comprimidos foram desenvolvidas: a primeira permitiu a análise simultânea de ETB e da impureza 2-amino-1-butanol por eletroforese capilar de zona (CZE) utilizando um eletrólito de corrida contendo 60,0 mmol L-1 de tampão ácido acético/acetato de sódio e 5,0 mmol L-1 de Cu2+, polaridade normal (+25 kV) e detecção UV em 262 nm. A segunda foi realizada por espectrofotometria com diluição dos padrões e amostras em 5,0 mmol L-1 de tampão ácido acético/acetato de sódio e 0,5 mmol L-1 de Cu2+ e detecção UV em 262 nm. A formação do complexo CuETB foi necessária em ambas as metodologias desenvolvidas, uma vez que ETB apresenta baixa absortividade molar. Algumas figuras de mérito, tais como, linearidade, repetitividade, exatidão, limite de detecção e limite de quantificação foram avaliadas para as duas metodologias. Os dois métodos foram comparados e não apresentaram diferenças significativas no intervalo de 95% usando o teste t não pareado com variância agrupada. Em um segundo momento, um novo método para análise simultânea de dose fixa combinada (DFC), contendo ETB, ISO, RIF e PIR por CZE com detecção UV foi desenvolvido, otimizado e validado. A condição experimental consistiu em um eletrólito contendo 50,0 mmol L-1 de tampão ácido acético/acetato de sódio e 12,5 mmol L-1 de Cu2+ e polaridade normal (+22 kV). Essa metodologia foi aplicada com sucesso na análise de 2-DFC (ISO e PIR) em comprimidos e 4-DFC (ETB, ISO, RIF e PIR) em sache. Finalmente, uma metodologia por CZE utilizando detecção UV para a análise simultânea de ISO, suas impurezas e produtos de degradação, como o ácido isonicotínico, isonicotinato de etila, 4-cianopiridina e isonicotinamida foi otimizada. A condição experimental consistiu em um eletrólito contendo 50,0 mmol L-1 de tampão ácido acético/acetato de sódio e 12,5 mmol L-1 de Cu2+, polaridade normal (+20 kV) e detecção UV em 270 nm. É importante ressaltar que planejamentos de experimentos, tais como, planejamento fatorial completo 32 e Box-Behnken 33 foram utilizados como ferramenta auxiliar no desenvolvimento e otimização das metodologias analíticas (CZE e espectofotométrica) e na avaliação da robustez para a análise de 4-DFC. / The main focus of this thesis was the development, optimization and validation of analytical methodologies for analysis of pharmaceutical preparations used for tuberculosis treatment, which contain as active ingredients, ethambutol (ETB), isoniazid (ISO), rifampicin (RIF) and pyrazinamide (PYR) isolated or in association. Two analytical methodologies for ETB analysis in tablets were developed initially: the first one took into account the capillary zone electrophoresis (CZE) approach for simultaneous analysis of ETB and its impurity 2-amino-1-butanol using an electrolyte consisting of 60.0 mmol L-1 of acetic acid/acetate buffer, 5.0 mmol L-1 of Cu2+, under normal polarity (+25 kV) and UV detection at 262 nm. The second one was performed by spectrophotometry using 5.0 mmol L-1 of acetic acid/acetate buffer and 0.5 mmol L-1 of Cu2+ for standards and sample dilutions under UV detection at 262 nm. The CuETB complex was necessary for the two methodologies, since ETB presents low molar absorptivity. Some merit figures such as linearity, repeatability, accuracy, limit of detection and limit of quantification were evaluated for both methodologies. These methodologies were compared and they did not present significant differences at the 95% confidence level using the parametric independent sample t test. In a second phase a novel method for the simultaneous analysis of fixed dose combination (FDC) containing ETB, ISO, RIF and PYR by CZE under UV detection was developed, optimized and validated. The experimental condition optimized consisted of an electrolyte containing 50.0 mmol L-1 of acetic acid/acetate buffer and 12.5 mmol L-1 of Cu2+ under normal polarity (+22 kV). This methodology was successfully applied to the analysis of 2-FDC (ISO and PYR) in tablet samples and 4-FDC (ETB, ISO, RIF and PYR) in a sachet sample. Finally, a CZE methodology using UV detection for simultaneous analysis of ISO, its impurities and degradation products such as isonicotinic acid, ethyl isonicotinate, 4-cyanopyridine and isonicotinamide was ptimized. The optimized experimental condition consisted of an electrolyte containing 50.0 mmol L-1 of acetic acid/acetate buffer and 12.5 mmol L-1 of Cu2+ under normal polarity (+20 kV) and UV detection at 270 nm. It is important to stress that design of experiment such as 32 full factorial design and 33 Box-Behnken design were used as auxiliary tools in the development and optimization of the analytical methodologies (CZE and spectrophotemetric) and robustness evaluation for 4-FDC analysis.

This diploma thesis deals with the development of an HPLC method for the determination of selected compounds participating in enzymatic reaction leading to the formation of gallic acid. The analysed reaction mixture contains the following reagents: shikimic acid, NADP+ and shikimatedehydrogenase (SDH) extracted from parsley; the presumed product of the reaction is gallic acid. Two chromatographic methods for the determination of the above mentioned compounds were developed using C18 HPLC column and porous graphitic carbon Hypercarb column. Molecular absorption spectrometric detection in the UV range was used in all measurements. Separation on the C18 column was found particularly suitable for analysing the composition of the end products of the reaction. Because of the NADP+ and shikimic acid peak overlap it is necessary to observe absorbance at 212 and 260 nm. Shikimic acid and NADP+ can be quantified due to the fact that shikimic acid does not absorb at 260 nm while NADP+ absorb radiation at both wavelengths. Separation via Hypercarb column was found particularly suitable for analysing the process of the reaction; additional products or intermediates can be seen in chromatograms compared to the C18 method. Determination with Hypercarb column is characterized by higher sensitivity and lower limit...

Biological markers (i.e., biomarkers) are essential in clinical and epidemiological studies as they may provide mechanistic insights into the developmental origins of disease, as well as improve diagnostic testing and risk assessment for disease prevention. However, major challenges remain due to the lack of rapid yet selective analytical methods for high throughput screening that are also amenable to volume-restricted specimens. This thesis includes two major research themes that take advantage of capillary electrophoresis (CE) separations, including (1) the targeted analysis of urinary iodide and thiocyanate for assessment of nutritional adequacy and tobacco smoke exposures in the population, and (2) the discovery of new biomarkers in sweat specimens that may improve universal newborn screening programs for cystic fibrosis (CF) infants beyond impaired chloride transport. Chapter II examines the prevalence and risk factors associated with iodine deficiency in 24 h urine samples collected from 800 participants across four clinical sites in Canada as part of the Prospective Urban and Rural Epidemiological (PURE) study when using CE with UV detection in conjunction with sample self-stacking. Importantly, regional variations in iodine status were revealed with participants from Quebec City and Vancouver at greater risk for iodine deficiency than Hamilton and Ottawa. Overall, iodine supplement use, thyroxine prescription, urinary sodium excretion, and self-reported dairy intake were found to be protective factors against iodine deficiency. Chapter III applied a validated CE assay to measure urinary thiocyanate as a biomarker of tobacco smoke and dietary exposures in an international cohort of 1000 participants from the PURE study spanning 14 countries with varied income status, smoking habits, and diet quality. Current smokers residing in high-income countries had the highest extent of cyanide exposure indicative of greater harms from tobacco smoke compared to middle- and low-income countries after adjusting for smoking intensity and other covariates. Chapter IV introduces a rapid CE method with indirect UV detection to simultaneously measure sweat chloride and bicarbonate from presumptive CF infants’ residual sweat samples. Although bicarbonate did not provide clinical value in neonatal CF diagnosis, sweat chloride testing by CE may reduce test failure rates due to insufficient volumes from infants in a clinical setting. Lastly, Chapter V applied an untargeted strategy to characterize the sweat metabolome from presumptive CF infants when using multisegment injection-capillary electrophoresis-mass spectrometry (MSI-CE-MS). A panel of sweat metabolites were found to discriminate CF from non-CF (i.e., unaffected carriers) infants, including aspartic acid, glutamine, oxoproline, and pilocarpic acid, which also correlated with sweat chloride. The clinical utility of these sweat metabolites to prognosticate late-onset CF infants from indeterminate sweat chloride test results was also explored. In summary, this thesis contributes innovative separation methods for biomarker screening and discovery in clinical and epidemiological studies for the prevention and early treatment of human diseases that benefit from optimal nutrition. / Dissertation / Doctor of Philosophy (PhD)

The innovative design of flat panel volume computed tomography (CT) systems has recently led to the emergence of a wide spectrum of new applications for both diagnostic and interventional purposes, such as ultra-high resolution bone imaging, image guided interventions, dynamic CT angiography, and interventional neuroradiology. Most of these applications require low X-ray dose to limit potential harm to the patient. One of the main challenges of low dose imaging is to maintain a quantum noise limited system to achieve the highest possible signal to noise ratio (SNR) at a given dose. One potential method to achieve a quantum noise limited system is to employ a high gain detector. Current flat panel CT technology is based on indirect conversion detectors that contain a scintillator and hydrogenated amorphous silicon (a-Si:H) p-i-n photodetectors which have a gain below unity and require a specialized p-layer. In this thesis, an alternative detector to the p-i-n photodetector, which can achieve gain above unity and thus aid in achieving quantum noise limited systems is investigated for large area flat panel imaging. The proposed detector is based on amorphous selenium (a-Se). Amorphous selenium is the most highly developed photoconductor for large area direct conversion X-ray imaging and is still the only commercially available large area direct conversion flat panel X-ray detector. However, the use of a-Se for indirect conversion imaging has not been significantly explored. Amorphous selenium has field dependent mobility and conversion efficiency, which increase with increasing electric field. It is also the only large area compatible avalanche-capable material; a property that was discovered more than 30 years ago. This unique property could be leveraged to provide the gain necessary for low dose medical imaging applications. The only current commercial avalanche capable a-Se optical detector uses electron beam readout in vacuum, which is not large area compatible and makes integration with pixelated readout electronics challenging. The detector structure proposed in this research seeks to address the challenges associated with integration of an avalanche capable a-Se detector with large area X-ray imager. One important aspect in the development of a-Se avalanche detectors is reducing the dark current and preventing a-Se breakdown as the electric field across the device is increased. A high dark current reduces the dynamic range of the detector, it increases the noise level, and it can lead to crystallization of the detector due to joule heating. To overcome the dark current problem, different blocking layers that allow for integration with large area flat panel imagers were investigated. Experimental results from fabricated devices provided the basis for the choice of the most suitable blocking layer. Two device structures are proposed using the selected blocking layer, a vertical structure and a lateral structure, each having associated benefits and drawbacks. It was shown that introducing a polyimide blocking layer brought down the dark current more than four orders of magnitude at high electric fields and does not deteriorate the charge transport properties of the detectors. The polyimide blocking layer also greatly minimizes physical stress related crystallization in a-Se improving reliability. Gain above unity was observed in the vertical structure and the initiation of impact ionization was verified by performing time-of-flight experiments. Although impact ionization was not verified in the lateral structure, this device structure was found to be highly sensitive to ultraviolet light due to the absence of a top contact layer. Devices were fabricated on several different substrates, including a CMOS substrate, to demonstrate their integration compatibility with large area readout electronics. The exhibited performance of the vertical device structure demonstrates that it is a suitable alternative to the p-i-n photodetector for low dose imaging applications.

Ces travaux de thèse ont permis de mettre en œuvre une méthode de criblage de l'activité antibactérienne des dendrimères greffés de la L-lysine (DGL) par électrophorèse capillaire (EC). Le principe de la méthode est basé sur le suivi du profil électrophorétique des bactéries avant et après leur rencontre avec une bande de composé cationique dont on souhaite cribler l'activité. La mise en œuvre de cette méthode a nécessité plusieurs étapes. Dans la première étape, une nouvelle méthodologie permettant la focalisation, la mobilisation et la quantification des bactéries par EC a été développée. Cette méthode a été appliquée pour la quantification de la flore totale dans des eaux naturelles. Dans la seconde étape, plusieurs revêtements neutres de capillaire ont été comparés pour l'analyse simultanée de composés polycationiques et polyanioniques. Dans la dernière partie, la méthodologie de criblage a été mise en œuvre pour l'étude de l'activité des DGL. / In this work, a new analytical methodology has been implemented for the screening of antibacterial activity of dendrigraft poly-L-lysines (DGL) by capillary electrophoresis (CE). The principle of this methodology is based on the monitoring of the electrophoretic profile of bacteria before and after the meeting with a zone containing the cationic compound to be screened. The implementation of this methodology has required several steps. In a first experimental part, a new methodology has been developed for the focalization, mobilization and quantification of bacteria. This focusing mode has been applied for the quantification of bacteria in natural waters. In a second experimental part, several neutral capillary coatings were compared for the simultaneous CE analysis of polyanionic and polycationic compounds. In the last experimental part, the screening of antibacterial activity has been implemented on DGL.

La cellulose et ses dérivés sont utilisés dans un vaste nombre d’applications incluant le domaine pharmaceutique pour la fabrication de médicaments en tant qu’excipient. Différents dérivés cellulosiques tels que le carboxyméthylcellulose (CMC) et l’hydroxyéthylcellulose (HEC) sont disponibles sur le commerce. Le degré de polymérisation et de modification diffèrent énormément d’un fournisseur à l’autre tout dépendamment de l’origine de la cellulose et de leur procédé de dérivation, leur conférant ainsi différentes propriétés physico-chimiques qui leurs sont propres, telles que la viscosité et la solubilité. Notre intérêt est de développer une méthode analytique permettant de distinguer la différence entre deux sources d’un produit CMC ou HEC. L’objectif spécifique de cette étude de maitrise était l’obtention d’un profil cartographique de ces biopolymères complexes et ce, par le développement d’une méthode de digestion enzymatique donnant les oligosaccharides de plus petites tailles et par la séparation de ces oligosaccharides par les méthodes chromatographiques simples. La digestion fut étudiée avec différents paramètres, tel que le milieu de l’hydrolyse, le pH, la température, le temps de digestion et le ratio substrat/enzyme. Une cellulase de Trichoderma reesei ATCC 26921 fut utilisée pour la digestion partielle de nos échantillons de cellulose. Les oligosaccharides ne possédant pas de groupements chromophores ou fluorophores, ils ne peuvent donc être détectés ni par absorbance UV-Vis, ni par fluorescence. Il a donc été question d’élaborer une méthode de marquage des oligosaccharides avec différents agents, tels que l’acide 8-aminopyrène-1,3,6-trisulfonique (APTS), le 3-acétylamino-6-aminoacridine (AA-Ac) et la phénylhydrazine (PHN). Enfin, l’utilisation de l’électrophorèse capillaire et la chromatographie liquide à haute performance a permis la séparation des produits de digestion enzymatique des dérivés de cellulose. Pour chacune de ces méthodes analytiques, plusieurs paramètres de séparation ont été étudiés. / Cellulose and its derivatives are used in a wide range of applications, including the pharmaceutical industry for the manufacturing of medicines as inactive additives. Various cellulosic derivatives such as carboxymethylcellulose (CMC) and hydroxyethylcellulose (HEC) are readily available for such use. The degree of polymerization and modification differs from one supplier to the other, according to the origin of the cellulose and its process of chemical modification, conferring on them different physico-chemical properties, such as viscosity and solubility. Our interest is to develop an analytical method that can distinguish between different sources of a given CMC or HEC product. The specific objective of this master’s study was to obtain a fingerprint of these complex biopolymers by developing an enzymatic digestion method to produce smaller oligosaccharides that could be separated by simple chromatographic methods. The digestion was studied as a function of various parameters, such as the composition of the hydrolysis solution, the pH, the temperature, the duration of digestion and the substrate/enzyme ratio. A cellulase enzyme from Trichoderma reesei ATCC 26921 was used for the partial digestion of our samples of cellulose. Since these oligosaccharides do not possess a chromophore or fluorophore, they can’t be detected either by absorbance or fluorescence. It was thus necessary to work out the labeling method for oligosaccharides using various agents, such as 8-aminopyrene-1,3,6-trisulfonic acid (APTS), 3-acetylamino-6-aminoacridine (AA-Ac) and phenylhydrazine (PHN). Finally, the use of capillary electrophoresis and high performance liquid chromatography allowed the separation of the enzymatic digestion products of the cellulose derivatives (CMC and HEC). For each of these analytical separation techniques, several parameters of the separation were studied.

La cellulose et ses dérivés sont utilisés dans un vaste nombre d’applications incluant le domaine pharmaceutique pour la fabrication de médicaments en tant qu’excipient. Différents dérivés cellulosiques tels que le carboxyméthylcellulose (CMC) et l’hydroxyéthylcellulose (HEC) sont disponibles sur le commerce. Le degré de polymérisation et de modification diffèrent énormément d’un fournisseur à l’autre tout dépendamment de l’origine de la cellulose et de leur procédé de dérivation, leur conférant ainsi différentes propriétés physico-chimiques qui leurs sont propres, telles que la viscosité et la solubilité. Notre intérêt est de développer une méthode analytique permettant de distinguer la différence entre deux sources d’un produit CMC ou HEC. L’objectif spécifique de cette étude de maitrise était l’obtention d’un profil cartographique de ces biopolymères complexes et ce, par le développement d’une méthode de digestion enzymatique donnant les oligosaccharides de plus petites tailles et par la séparation de ces oligosaccharides par les méthodes chromatographiques simples. La digestion fut étudiée avec différents paramètres, tel que le milieu de l’hydrolyse, le pH, la température, le temps de digestion et le ratio substrat/enzyme. Une cellulase de Trichoderma reesei ATCC 26921 fut utilisée pour la digestion partielle de nos échantillons de cellulose. Les oligosaccharides ne possédant pas de groupements chromophores ou fluorophores, ils ne peuvent donc être détectés ni par absorbance UV-Vis, ni par fluorescence. Il a donc été question d’élaborer une méthode de marquage des oligosaccharides avec différents agents, tels que l’acide 8-aminopyrène-1,3,6-trisulfonique (APTS), le 3-acétylamino-6-aminoacridine (AA-Ac) et la phénylhydrazine (PHN). Enfin, l’utilisation de l’électrophorèse capillaire et la chromatographie liquide à haute performance a permis la séparation des produits de digestion enzymatique des dérivés de cellulose. Pour chacune de ces méthodes analytiques, plusieurs paramètres de séparation ont été étudiés. / Cellulose and its derivatives are used in a wide range of applications, including the pharmaceutical industry for the manufacturing of medicines as inactive additives. Various cellulosic derivatives such as carboxymethylcellulose (CMC) and hydroxyethylcellulose (HEC) are readily available for such use. The degree of polymerization and modification differs from one supplier to the other, according to the origin of the cellulose and its process of chemical modification, conferring on them different physico-chemical properties, such as viscosity and solubility. Our interest is to develop an analytical method that can distinguish between different sources of a given CMC or HEC product. The specific objective of this master’s study was to obtain a fingerprint of these complex biopolymers by developing an enzymatic digestion method to produce smaller oligosaccharides that could be separated by simple chromatographic methods. The digestion was studied as a function of various parameters, such as the composition of the hydrolysis solution, the pH, the temperature, the duration of digestion and the substrate/enzyme ratio. A cellulase enzyme from Trichoderma reesei ATCC 26921 was used for the partial digestion of our samples of cellulose. Since these oligosaccharides do not possess a chromophore or fluorophore, they can’t be detected either by absorbance or fluorescence. It was thus necessary to work out the labeling method for oligosaccharides using various agents, such as 8-aminopyrene-1,3,6-trisulfonic acid (APTS), 3-acetylamino-6-aminoacridine (AA-Ac) and phenylhydrazine (PHN). Finally, the use of capillary electrophoresis and high performance liquid chromatography allowed the separation of the enzymatic digestion products of the cellulose derivatives (CMC and HEC). For each of these analytical separation techniques, several parameters of the separation were studied.

L’objectif de ce projet doctoral a été de coupler la chromatographie en phase supercritique (SFC) avec un spectromètre de masse haute résolution pour l’analyse de substances naturelles apolaires. La SFC est une technique dite « verte » contrairement à la chromatographie liquide en phase normale (NPLC), très consommatrice de solvants organiques toxiques pour l’environnement, puisque la phase mobile est principalement constituée de CO2. Le CO2 ayant une faible viscosité, cela implique une diffusivité, des débits élevés et des temps d’analyse courts. Notre attention a été focalisée sur des molécules apolaires : les lipides. Le but était de mettre au point des dosages dans des matrices alimentaires et biologiques et de débuter une approche lipidomique d’étude de la maladie de Parkinson. La première partie a été dédiée au développement du système SFC avec une détection UV, prêté par le constructeur Agilent Technologies. La première étude s’est portée sur 6 composés de la famille des vitamines A. Une phase d’optimisation a été réalisée afin d’obtenir une séparation satisfaisante des composés, en testant différents paramètres chromatographiques comme le type de phase stationnaire ou encore la composition de la phase mobile, afin d’obtenir une résolution optimale. Ensuite, des études de linéarité et de répétabilité ont été réalisées et des limites de détection et de quantification ont été déterminées afin d’obtenir une méthode fiable et robuste. Une deuxième partie a concerné la mise en place du couplage entre la SFC et un spectromètre de masse de type quadripôle-temps de vol (Q-TOF), afin d’améliorer la spécificité et la sensibilité des analyses. Différentes sources d’ionisation ont été utilisées : ESI, APCI et APPI. Chacune des sources présente des modes d’ionisation différents, qui permettent de pouvoir balayer une large gamme de polarité des analytes. Nous avons choisi 8 dérivés de la vitamine E, composés apolaires pour lesquels la SFC paraît être la technique d’analyse idéale. La séparation de ces composés a été optimisée de façon à obtenir une bonne résolution chromatographique et un temps d’analyse minimal. L’ionisation des composés est réalisée avec les 3 sources disponibles en faisant varier les paramètres de sources ou encore le solvant « make-up », de façon à obtenir une sensibilité optimale. La source APPI a été finalement choisie après une étude sur les performances de la méthode. Cette source présente une bonne répétabilité, linéarité et des limites de détection de l’ordre de celles retrouvées dans la littérature par HPLC-MS. Nous avons ensuite réalisé la quantification des ces composés dans 2 types de matrices alimentaire et biologique : l’huile de soja et le plasma de rat. Une troisième partie a été débutée sur le profilage de lipides à polarités variées par SFC-MS. Cette technique se révèle idéale de par la faible polarité de ces composés et leur absence d’absorbance dans le domaine UV. En effet, l’intégrité des lipides peut être altérée suite aux dommages causés par les radicaux libres, qui sont potentiellement impliqués dans de nombreuses maladies neurodégénératives. Il parait primordial de développer des outils analytiques présentant une haute sensibilité et résolution et la possibilité d’accéder aux informations structurales. La source d’ionisation ESI nous a permis de détecter 12 lipides sur les 20 sous-classes analysées en mode positif et 8 lipides en mode négatif. Une application a été réalisée sur un échantillon de plasma humain. Il serait intéressant à l’avenir d’effectuer cette étude en utilisant la source APPI, source propice à l’analyse structurale de lipides et présentant une bonne sensibilité et répétabilité. Ce couplage SFC-MS, présentant une bonne sensibilité et répétabilité, sera par la suite étendu à l’analyse de lipides dans diverses matrices biologiques et pourra à l’avenir être appliqué à l’étude de nouveaux biomarqueurs et au screening rapide d’un grand nombre d’échantillons / The aim of this PhD project was to couple supercritical fluid chromatography (SFC) with a high resolution mass spectrometer for apolar natural compounds analysis. Because mobile phase is principally constituted of CO2, SFC is called “green technic” contrary to normal phase liquid chromatography (NPLC), which uses lot of organic solvents toxic for environment. The CO2 presents a low viscosity, in this way high diffusivity and flow rate, and lower analysis times are obtained. Our work was focused on apolar molecules: the lipids. The aim was to quantify molecules in alimentary and biological matrices and to a lipidomic approach to study Parkinson disease. The first part was to develop the system SFC with a UV detection on a system on loan by Agilent Technologies. This first study was carried out on 6 vitamin A compounds. An optimization of chromatographic parameters has been realized in order to obtain a good separation of the compounds. Then, linearity, repeatability, detection and quantification limits have been determined in order to have a reliable and robust method. A second part concerned the coupling of SFC and a quadrupole time-of-flight mass spectrometer (Q-TOF), in order to improve specificity and sensitivity of analysis. Different ionization sources have been tested: ESI, APCI and APPI. Each ion source presents different ionization mode, which permits to analyze a wide range of polarities of compounds. We have chosen 8 vitamin E derivatives, which are apolar compounds for which SFC seems to be well suited. Separation compounds have been optimized in order to have a good chromatographic resolution and a short analysis time. This compounds ionization is realized with the 3 sources, varying ionization parameters and make-up solvent, to have an optimal sensitivity. The APPI source has been chosen after a performance evaluation method. This source presents a good repeatability, linearity and detection limit in the same order of magnitude than those found in the literature by HPLC-MS. Then we have quantified these compounds in alimentary and biological matrices: a soya oil and plasma rat. A third study has been started on lipid profiling with various polarities by SFC-MS. This technic is well suited because of the low polarity of this molecules and their lack of absorbance in the UV range. The integrity of lipids can be altered with damages caused by free radicals, and are potentially involved in neurodegenerative diseases. It is essential to develop analytical systems with a high sensitivity and resolution and the possibility to access to structural information. The ESI source permits to detect 12 lipids on the 20 sub-classes analyzed in positive ion mode and 8 lipids in negative mode. An application has been realized on human plasma. In the future, it will be interesting to analyze these lipids with the APPI source, which is good choice for structural analysis of lipids, with good sensitivity and repeatability. Studies with this SFC-MS system, presenting good sensitivity and repeatability, will be extended to lipid analysis in biological matrices and could be applied to new biomarkers study and for fast screening of a large number of samples